Nuzenio

Partners Leerink Partners

Partners Leerink Partners news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 11:59:08 GMTCYTOKINETICS, INCORPORATED : LEERINK PARTNERS RAISES TARGET PRICE TO $103 FROM $100 - Bitget
Sat, 08 Aug 2026 00:30:00 GMTAkebia Therapeutics Price Target Announced at $1.00/Share by Leerink Partners - Moomoo
Fri, 07 Aug 2026 14:59:35 GMTHALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83 - Bitget
Fri, 07 Aug 2026 13:09:52 GMTAkebia Therapeutics (NASDAQ:AKBA) Downgraded by Leerink Partners to "Market Perform" - MarketBeat
Fri, 07 Aug 2026 13:09:51 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to "Outperform" at Leerink Partners - MarketBeat
Fri, 07 Aug 2026 13:00:35 GMTLeerink Partners Adjusts Price Target on Cencora to $380 From $368 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Partners Leerink Partners.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.